Capcytebio
1 known investors
CapCyte Bio develops a patented surface modification technology combining oriented antibodies and biomimetic peptides to functionalize materials for selective capture and activation of progenitor cells. Its applications include enhancing the biocompatibility and regenerative potential of cardiovascular implants and enabling cell culture devices for faster isolation and expansion of rare therapeutic cells.